Company Monitoring Page for Omeros

latest headlines for company on cafepharma

Omeros terminates kidney disease trial as therapy fails in late-stage study
Reuters
Mon, 10/16/23 - 10:15 am
Tags:
Omeros, kidney disease, clinical trials, narsoplimab, Berger's disease
Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Tags:
Aldeyra Therapeutics, Autolus Therapeutics, Bavarian Nordic, BioXcel Therapeutics, Disc Medicine, Editas Medicine, Immunogen, Lantheus, Mersana Therapeutics, NGM Biopharmaceuticals, Omeros, Roche, Sutro BioPharma, uniQure, Valneva, Viking Therapeutics
After rejection and appeal, Omeros saddles up for 2nd charge at transplant drug approval
BioSpace
Tue, 03/14/23 - 10:59 am
Tags:
Omeros, transplant-associated thrombotic microangiopathy, organ transplants, narsoplimab
Omeros' Hail Mary throw for blood clot med application delayed at FDA
Fierce Biotech
Wed, 08/17/22 - 12:12 pm
Tags:
Omeros, FDA, narsoplimab
A Seattle biotech offloads lead eye drug in deal valued at $1B+ as it refocuses on emerging pipeline
Endpoints
Thu, 12/2/21 - 11:00 am
Tags:
Omeros, Omidria, cataract surgery, post-operative pain, Rayner Surgical
FDA rejects Omeros transplant drug over difficulties estimating its effect
Fierce Biotech
Mon, 10/18/21 - 11:14 am
Tags:
FDA, organ transplant, stem cells, Omeros
Omeros Reports Coronavirus Treatment Success; Stock Soars
Investors Business Daily
Mon, 08/10/20 - 10:58 am
Tags:
Omeros, clinical trials, COVID-19, narsoplimab
Omeros hits endpoint in pivotal stem cell transplant study
Fierce Biotech
Wed, 12/4/19 - 09:58 am
Tags:
Omeros, narsoplimab, stem cells, stem cell transplant, clinical trials
FDA Grants Orphan Drug Designation to Omeros’ Treatment for Stem Cell Transplant-Associated Thrombotic Microangiopathy
CP Wire
Tue, 10/23/18 - 11:00 pm
Tags:
Omeros, OMS721, stem cells, thrombotic microangiopathy
Tue, 10/23/18 - 09:43 am
Tags:
Omeros, OMS721, stem cell, thrombotic microangiopathy
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Tags:
Adamis, GSK, Sangamo BioSciences, Roche, Bluebird Bio, ProQR Therapeutics, Geron, Amarin, Palatin, EyeGate, Galactin, Omeros, Atossa Genetics
Omeros Receives Orphan Designation in Europe for Treatment in Hematopoietic Stem Cell Transplantation
CP Wire
Wed, 08/29/18 - 10:26 am
Tags:
Omeros, OMS721, thrombotic microangiopathy
Tue, 08/28/18 - 11:53 am
Tags:
Omeros, OMS721, thrombotic microangiopathy
Omeros Prevails in Patent Dispute With Sandoz
CP Wire
Thu, 07/26/18 - 11:24 am
Tags:
Omeros, Sandoz, Novartis, patents, Omidria
Thu, 07/26/18 - 09:12 am
Tags:
Omeros, Omidria, Sandoz, lawsuits, patent lawsuits
New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores
TheStreet.com
Fri, 03/23/18 - 09:50 am
Tags:
Big Pharma, Medicare Part D, Omeros, Omnibus Bill
5 Small Biotechs Receive Shots in the Arm
TheStreet.com
Mon, 11/13/17 - 09:22 am
Tags:
earnings, Synergy Pharmaceuticals, Omeros, BioDelivery Sciences, Heron Therapeutics, Dynavax
Omeros defends its drug, but still won’t answer basic questions
Stat
Wed, 08/23/17 - 10:19 pm
Tags:
Omeros, OMS721
These 3 Biotech Stocks Have Doubled This Year; Can They Keep Climbing?
Motley Fool
Tue, 06/27/17 - 11:52 pm
Tags:
biotech, Omeros, Cara Therapeutics, Portola Pharmaceuticals
Biotech Movers: OncoMed, Incyte, Omeros
TheStreet.com
Mon, 04/17/17 - 11:22 am
Tags:
biotech, OncoMed, tarextumab, small cell lung cancer, Incyte, Eli Lilly, baricitinib, Omeros

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.